Cel Sci CVM
NYSE CVM
$1.42 -0.04 (-2.74%)
At close: Aug 21, 2026 · 4:00 PM EDT

Cel Sci (CVM) Other Accumulated Expenses (2015 - 2020)

Cel Sci (CVM) posted Other Accumulated Expenses of $5000.0 for Q1 2020, little changed sequentially from $5000.0 in Q4 2019, and down 64.24% YoY from $13984.0 in Q2 2019.

Cel Sci (CVM) Other Accumulated Expenses (2015 - 2020) Analysis & Trends

Cel Sci has reported Other Accumulated Expenses for 6 years, with the latest figure at $5000.0 in Q1 2020.

  • Quarterly Other Accumulated Expenses fell 64.24% year-over-year to $5000.0 in Q1 2020, while the trailing twelve-month figure through Mar 2020 was $5000.0 (down 64.24% YoY) and the FY2019 annual result came in at $14956.0, up 6.61% from the prior year.
  • Other Accumulated Expenses steadied at $5000.0 in Q1 2020 per CVM's latest filing, from $5000.0 in the prior quarter.
  • Over five years, Other Accumulated Expenses peaked at $16009.0 in Q2 2019 and troughed at $3310.0 in Q3 2016.
  • A 5-year average of $11003.5 and a median of $12449.0 in 2017 frame the typical range for Other Accumulated Expenses.
  • The sharpest annual moves came in 2016 and 2017: Other Accumulated Expenses plunged 82.6% in 2016, then surged 276.1% in 2017.
  • Over 5 years, Other Accumulated Expenses stood at $7203.0 in 2016, then soared by 64.03% to $11815.0 in 2017, then climbed by 16.54% to $13769.0 in 2018, then slumped by 63.69% to $5000.0 in 2019, then changed by 0.0% to $5000.0 in 2020.
  • According to Business Quant data, Other Accumulated Expenses over the past three periods registered $5000.0, $5000.0, and $14956.0 for Q1 2020, Q4 2019, and Q3 2019 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 Cel Sci 2.12 Mn -4.42 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2020 5,000.00
Dec 31, 2019 5,000.00
Sep 30, 2019 14,956.00
Jun 30, 2019 16,009.00
Mar 31, 2019 13,984.00
Dec 31, 2018 13,769.00
Sep 30, 2018 14,029.00
Jun 30, 2018 14,290.00
Mar 31, 2018 14,576.00
Dec 31, 2017 11,815.00
Sep 30, 2017 12,449.00
Jun 30, 2017 10,871.00
Mar 31, 2017 7,792.00
Dec 31, 2016 7,203.00
Sep 30, 2016 3,310.00
Sep 30, 2015 19,025.00